Results 81 to 90 of about 822 (142)

In vitro-Aktivität von Ibrexafungerp gegen klinische echinocandin-resistente Candida Stämme

Invasive Pilzinfektionen stellen ein zunehmendes Problem in der globalen Gesundheitsversorgung dar. Intravenös verabreichte Echinocandine waren bisher zumeist die Standardtherapie bei invasiven Candidosen, doch zunehmende Resistenzen führen vermehrt zu Therapieversagen und einer höheren Mortalität.
openaire   +2 more sources

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents. [PDF]

J Fungi (Basel)
Quindós G, De-la-Pinta I, Marcos-Arias C, Jauregizar N, Sevillano E, Madariaga L, Eraso E.   +6 more
europepmc   +1 more source

State-of-the-Art Review: Managing Vulvovaginal Candidiasis. [PDF]

Clin Infect Dis
Rautemaa-Richardson R, Sobel JD, Stone N, De Seta F, Cassone A, Vieira-Baptista P, Comar M, Warris A, Roselletti E.   +8 more
europepmc   +1 more source

Ibrexafungerp prolongs survival and reduces the eumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma. [PDF]

J Antimicrob Chemother
Ma J, Eadie K, Konings M, Fahal A, Verbon A, van de Sande WWJ.   +5 more
europepmc   +1 more source

Refractory <i>Candidozyma</i> (<i>Candida</i>) <i>auris</i>-associated central nervous system infection in a postoperative neurosurgical patient. [PDF]

ASM Case Rep
Xue YC, Thomas K, Zaidan N, Ren P.
europepmc   +1 more source

Beyond antifungals: vaginal ceramides as a barrier-restorative strategy for recurrent vulvovaginal candidiasis in Ehlers-Danlos syndrome. [PDF]

Ann Med Surg (Lond)
Amjad M, Fazal M, Talha M, Ali U, Mahato RK.   +4 more
europepmc   +1 more source

The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets. [PDF]

J Fungi (Basel)
Marena GD, Carvalho GC, Magalhães MHC, Figueiredo JM, Ramos DH, Nosanchuk JD, Taborda CP.   +6 more
europepmc   +1 more source

<i>Candida auris</i>: host interactions, antifungal drug resistance, and diagnostics. [PDF]

Microbiol Mol Biol Rev
Chowdhary A, Lionakis MS, Chauhan N.
europepmc   +1 more source

The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]

JHLT Open
Lowe A, King ST, Hand J.
europepmc   +1 more source

Faculty Opinions recommendation of The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2021
openaire   +2 more sources